How Thalassemias Cause Anemia
Thalassemias cause anemia through two primary mechanisms: ineffective erythropoiesis (destruction of red blood cell precursors in the bone marrow) and hemolysis (premature destruction of circulating red blood cells), with ineffective erythropoiesis being the dominant mechanism. 1
Primary Pathophysiologic Mechanism
Globin Chain Imbalance
The fundamental defect in thalassemia is reduced or absent production of specific globin chains, leading to an imbalance between alpha and beta globin chains 1, 2:
- β-thalassemia: Severe reduction or absent β-globin chain production results in excess unpaired α-globin chains 1
- α-thalassemia: Reduced α-globin production leads to excess β-globin chains 3
Ineffective Erythropoiesis (Primary Mechanism)
The excess unpaired globin chains accumulate in erythroid precursors and precipitate, causing oxidative stress and premature apoptotic death of these cells in the bone marrow 1, 2, 4. This process is called ineffective erythropoiesis and is more important than hemolysis in causing the anemia 5.
The mechanism involves:
- Unpaired globin chains with heme attached accumulate in developing red blood cells
- These complexes generate oxidative damage
- Erythroid precursors undergo premature apoptosis through FAS/FAS-Ligand activation 5
- Intramedullary destruction occurs before cells can mature and enter circulation 2
Hemolysis (Secondary Mechanism)
Red blood cells that do reach circulation are abnormal and undergo premature destruction 2, 5:
- Membrane instability: The membrane skeleton (spectrin, actin, band 4.1) becomes unstably attached due to oxidized globin chain deposition 6
- Oxidant injury: Oxidative damage to membrane proteins (protein 4.1, band 3) causes structural weakness 5
- Rigid but unstable cells: Thalassemic red blood cells are rigid yet mechanically unstable, leading to premature lysis 6
Clinical Severity Spectrum
The severity of anemia correlates directly with the degree of globin chain imbalance 4:
- β-thalassemia major: Profound, life-threatening anemia from age 1-2 years requiring lifelong transfusions 1
- Thalassemia intermedia: Variable anemia, generally not requiring regular transfusions 1
- α-thalassemia major: Severe hemolytic anemia typically leading to hydrops fetalis 3
Important Clinical Caveat
The anemia in thalassemia is fundamentally different from simple blood loss or nutritional deficiency—it represents a failure of red blood cell production at the bone marrow level combined with accelerated destruction. This is why transfusion therapy aims not just to correct hemoglobin levels but to suppress the ineffective erythropoiesis by maintaining pre-transfusion hemoglobin at 9-10 g/dL 1.